Elsevier, Translational Oncology, Volume 16, February 2022
Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in the United States. Despite increased screening options and state-of-art treatments offered in clinics, racial differences remain in CRC. African Americans (AAs) are disproportionately affected by the disease; the incidence and mortality are higher in AAs than Caucasian Americans (CAs). At the time of diagnosis, AAs more often present with advanced stages and aggressive CRCs, primarily accounting for the racial differences in therapeutic outcomes and mortality.
Elsevier, European Economic Review, Volume 141, January 2022
We study whether there is a racial bias in ratings of professional football players in Italian newspapers. We find that there is such a bias. Conditional on objective performance indicators black players receive a lower rating than non-black players. This is not a difference across the board but predominantly present at the lower end of the newspaper rating distribution. The best black players are not subject to a racial bias in ratings. We also find that clubs do not have a racial bias in the wages they pay to players.
Elsevier, SSM - Population Health, Volume 16, December 2021
Research suggests that racial/ethnic disparities in COVID-19 in the US are largely driven by higher rates of exposure to SARS-CoV-2 among Hispanic/Latino and Black populations. Occupational exposures play a large role in structuring risk of exposure, and essential workers are at elevated risk of COVID-19 infection. At a national-level, workers categorized as “essential” and “high-risk” are disproportionately Hispanic/Latino, but we lack analysis examining local-level racial/ethnic disparities in potential occupational exposures.
Elsevier, Blood Advances, Volume 5, 9 November 2021
Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials
Data regarding racial and ethnic enrollment diversity for acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL) clinical trials in the United States are limited, and little is known about the effect of federal reporting requirements instituted in the late 2000s. We examined demographic data reporting and enrollment diversity for ALL and AML trials in the United States from 2002 to 2017, as well as changes in reporting and diversity after reporting requirements were instituted.
Elsevier, Annals of Emergency Medicine, Volume 78, November 2021
The COVID-19 pandemic has shed light on the ongoing pandemic of racial injustice. In the context of these twin pandemics, emergency medicine organizations are declaring that “Racism is a Public Health Crisis.” Accordingly, we are challenging emergency clinicians to respond to this emergency and commit to being antiracist. This courageous journey begins with naming racism and continues with actions addressing the intersection of racism and social determinants of health that result in health inequities.
Elsevier, Chest, Volume 160, July 2021
Background: Criteria for low-dose CT scan lung cancer screening vary across guidelines. Knowledge of the eligible pool across demographic groups can enable policy and programmatic decision-making, particularly for disproportionately affected populations. Research Question: What are the eligibility rates for low-dose CT scan screening according to sex and race or ethnicity and how do these rates relate to corresponding lung cancer incidence rates?